Industry Newsrevenue cycle managementhealthcare softwarewaystaranalyst coverage
UBS Analyst Gives Waystar Buy Rating
6.0
UBS analyst Kevin Caliendo initiated coverage of Waystar Holding Corp. (NASDAQ:WAY) on December 15, assigning a Buy rating and setting a $41 price target, implying roughly 25% upside. Caliendo cited Waystar’s position in cloud-based revenue-cycle management, the Iodine Software acquisition, and an industry shift toward AI-enabled automation; as of December 19, 16 of 17 analysts rate the stock Buy with a $48.44 average target (47.5% upside).
Key Points
- 1Assigns Buy rating with $41 target, implying roughly 25% upside from current levels
- 2Highlights industry shift to AI-enabled automation and Iodine acquisition expanding addressable market and cross-selling
- 3Signals strong analyst consensus: 16 of 17 coverages are Buys, average target $48.44, 47.5% upside
Scoring Rationale
Provides credible analyst-backed investment thesis and market data, but is primarily an equity rating update for a single company.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
